First, it is known that diabetes is often associated with various diseases (Coady et al., 2019; Fisher et al., 2020; Mattin et al., 2007); however, the effect of administering SGLT2 inhibitors on these diseases was not addressed in this study. The gene discussed is SLC5A2; the disease is diabetes mellitus.